SEC Form 4 · accession 0001232524-16-000315
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Bruce C Cozadd
Officer — Chairman & CEO · Director
Period of report
Aug 9, 2016
Accepted (ET)
Aug 11, 2016 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Aug 9, 2016 | S | 1,000 | $150.00 | D | 299,184 | D | |
| Ordinary Shares | Aug 9, 2016 | F | 9,071 | $150.01 | D | 290,113 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Includes 118 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2016.
- F3Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.